Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021
This report describes the Advisory Committee on Immunization Practices' (ACIP) conclusion that the benefits of COVID-19 vaccination outweigh the risks of myocarditis.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=424154
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021
Among 26,174 surveyed state, tribal, local, and territorial public health workers, 53% reported symptoms of at least one mental health condition in the past 2 weeks. Symptoms were more prevalent among those who were unable to take time off from work or who felt bullied, threatened, or harassed because of work.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423827
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021
The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422061
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021
Overall, 34% of adults aged 18-39 years reported having received a COVID-19 vaccine. Adults aged 18-24 years, as well as non-Hispanic Black adults and those with less education, no health insurance, and lower household incomes, had the lowest reported vaccination coverage and intent to get vaccinated. Concerns about vaccine safety and effectiveness were commonly cited barriers to vaccination.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423690
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021
On January 24, the Colorado Department of Public Health and Environment (CDPHE) identified the first Colorado case of COVID-19 attributed to the B.1.427 and B.1.429 variants. To improve convenience sampling to identify and track emerging variants, CDPHE established a 30-site statewide sentinel surveillance system.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421658
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021
By May 22, 2021, 57% of U.S. adults aged 18 and older had received ≥1 COVID-19 vaccine doses; coverage was lower and increased more slowly over time among younger adults. If the current rate of vaccination continues through August, coverage among young adults will remain substantially lower than among older adults.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423689
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021
As of May 2021, 16% of pregnant people identified in CDC's Vaccine Safety Datalink had received ≥1 dose of a COVID-19 vaccine during pregnancy in the U.S. Vaccination was lowest among Hispanic people (12%), non-Hispanic Black people (6%), and people aged 18-24 years (6%), and highest among non-Hispanic Asian people (25%) and people aged 35-49 years (23%).
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423566
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021
During the COVID-19 pandemic, emergency department (ED) visits for suspected suicide attempts increased among adolescents aged 12-17 years, especially girls. During February-March 2021, suspected suicide attempt ED visits were 51% higher among girls aged 12-17 years than during 2019; among boys aged 12-17 years, suspected suicide attempt ED visits increased 4%.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423473
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542
Etiketler:


EklenmeTarihi: 29 Kasım 2021, Pazartesi, 12:07
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539
Etiketler: